Ketomar Eye Drops(Ketotifen 0.025%)

Therapeutic Group: Ophthalmic Presentation Ketomar Eye Drops: Each ml Ketomar eye drop contains Ketotifen Fumarate BP equivalent to Ketotifen 0.25mg. Description Ketotifen is a potent anti-allergic substance possessing a powerful and sustained non-competitive histamine (H1) receptor blocking property. Ketotifen inhibits the release of mediators from cells responsible for type I allergic reactions. Ketotifen also stabilizes […]

Ketomar(Ketotifen)

Therapeutic Group: Anti Histamine Presentation Ketomar Tablet: Each tablet contains Ketotifen Fumarate BP 1.38 mg equivalent to Ketotifen 1 mg. Ketomar Syrup: Each 5 ml syrup contains Ketotifen Fumarate BP 1.38 mg equivalent to Ketotifen 1 mg. Description Ketotifen is a nonbronchodilator anti-asthmatic drug which inhibits the effects of certain endogenous substances known to be […]

Etorac(Ketorolac)

Therapeutic Group: Analgesic, Anti Inflammatory Presentation Etorac 30 IM/IV injection: Each 1 ml ampoule contains concentrated sterile solution of ketorolac Tromethamine USP 30 mg. Etorac 60 IM injection: Each 2 ml ampoule contains concentrated sterile solution of Ketorolac Tromethamine USP 60 mg. Etorac tablet : Each film coated tablet contains Ketorolac Tromethamine USP 10 mg. […]

Dancel Shampoo(Ketoconazole)

Therapeutic Group: Skin Presentation Dancel Shampoo: Each gram shampoo contains Ketoconazole BP 20 mg Description Ketoconazole, a synthetic imidazole dioxolane derivative, has a potent antifungal activity against dermatophytes, such as Trichophyton sp., Epidermophyton sp., Microsporum sp., and yeasts, such as Candida sp. and Malassezia spp.(Pityrosporum spp). Ketoconazole 2% shampoo rapidly relieves scaling and pruritus, which […]

Ketaride(Ketamine)

Therapeutic Group: Anesthetic / Critical Care Presentation Each vial contains 10 ml solution of Ketamine Hydrochloride USP equivalent to 500 mg Ketamine base. Description Ketaride (ketamine as hydrochloride) is a non-barbiturate anesthetic. Ketamine is a racemic mixture. It is formulated as an acid (pH 3.5 to 5.5) solution for intravenous or intramuscular injection. Indications Ketaride […]

Parakil Plus Vet(Ivermectin)

Therapeutic Group: Anthelmintic Presentation Parakil Plus vet Injection: Each ml injectable solution contains Ivermectin BP 10 mg &Clorsulon USP 100 mg. Description Ivermectin is a derivative of Avermectins, a family of potent broad-spectrum anthelmintic. Ivermectin binds selectively with high affinity to glutamate-gated chloride ion channels results in the permeability of the cell membrane to chloride […]

Parakil Vet(Ivermectin)

Therapeutic Group: Anthelmintic Presentation Parakil vet Injection: Each ml injection contains Ivermectin BP 10 mg. Description Ivermectin is derivatives of Avermectins, a family of potent broad-spectrum anthelmintic. Ivermectin binds selectively with high affinity to glutamate-gated chloride ion channels results in the permeability of the cell membrane to chloride ions with hyperpolarization of the nerve or […]

Parakil(Ivermectin)

Therapeutic Group: Anti-parasite Presentation Parakil 6 Tablet: Each tablet contains Ivermectin USP 6 mg Description Ivermectin is a derivative of Avermectins, a family of potent broad-spectrum anthelmintic. Ivermectin binds selectively with high affinity to glutamate-gated chloride ion channels resulting to an increase in the permeability of the cell membrane to chloride ions with hyperpolarization of […]

Ivaprex(Ivabradine)

Therapeutic Group: Cardiovascular Presentation Ivaprex 5: Each film coated tablet contains Ivabradine Hydrochloride INN equivalent to Ivabradine 5 mg. Ivaprex 7.5: Each film coated tablet contains Ivabradine Hydrochloride INN equivalent to Ivabradine 7.5 mg. Description Ivabradine is a new class of selective heart rate lowering agent. It acts by selective and specific inhibition of cardiac […]

Aric(Istradefylline)

Therapeutic Group: Others Presentation AricTM 20: Each tablet contains Istradefylline INN 20 mg Description The precise mechanism by which Istradefylline exerts its therapeutic effect in Parkinson disease is unknown. In studies, Istradefylline is demonstrated to be an adenosine A2A receptor antagonist. Indications Istradefylline is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in […]